| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 10/02/2008 | WO2008037568A3 Reversible terminators for efficient sequencing by synthesis |
| 10/02/2008 | US20080242683 Antiinflammatory agents; chronic obstructive pulminary disease |
| 10/02/2008 | US20080241833 Using primer extension to determine sequence of single nucleotide polymorphism; gene expression analysis |
| 10/01/2008 | EP1975256A1 Modified oligonucleotides for mismatch discrimination |
| 10/01/2008 | EP1975172A2 High affinity TGFß nucleic acid ligands and inhibitors |
| 10/01/2008 | EP1974732A1 Therapeutic agent for neurodegenerative disease |
| 10/01/2008 | EP1973925A1 Dna chip for diagnosis of corneal dystrophy |
| 09/30/2008 | US7429651 Fluorescent nucleobase conjugates having anionic linkers |
| 09/30/2008 | US7429572 Modified fluorinated nucleoside analogues |
| 09/30/2008 | US7429571 4-Amino-7- beta -(2'-C-methyl-D-ribofuranosyl)-furo[3,2-d]pyrimidine; anticancer agents |
| 09/30/2008 | CA2264953C Modifying insect cell gylcosylation pathways with baculovirus expression vectors |
| 09/24/2008 | CN101273051A Polymeric oligonucleotide prodrugs |
| 09/23/2008 | US7427679 Sugar with heterocyclic base having exocyclic amine group and substituted or unsubstituted triaryl methyl protecting group bound to exocyclic amine group |
| 09/23/2008 | US7427673 Labelled nucleotides |
| 09/23/2008 | US7427672 Artificial nucleic acids of n-o bond crosslinkage type |
| 09/23/2008 | US7427606 Method to reduce inflammatory response in transplanted tissue |
| 09/18/2008 | WO2008111908A1 Five- and six-membered conformationally locked 2',4'- carbocyclic ribo-thymidines for the treatment of infections and cancer |
| 09/18/2008 | WO2008111485A1 Compound having structure derived from mononucleoside or mononucleotide, nucleic acid, labeling substance, and method and kit for detection of nucleic acid |
| 09/18/2008 | WO2008111082A1 Process for the synthesis of ib-meca |
| 09/18/2008 | WO2008085508A3 Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection |
| 09/18/2008 | US20080227970 Sequencing nucleic acid molecules; promote accurate base-over-base incorporation in sequencing-by-synthesis reactions, resulting in greater read lengths |
| 09/18/2008 | US20080227964 2'-silyl containing thiocarbonate protecting groups for RNA synthesis |
| 09/18/2008 | US20080227754 Phosphoramidate linkages; retroviral or hepadnaviral therapy; tissue targeted therapy; HIV/aquired immunodeficiency syndrome; antitumor agents; improved bioavailability |
| 09/18/2008 | US20080227653 Expression monitoring by hybridization to high density oligonucleotide arrays |
| 09/17/2008 | EP1968612A2 Nucleotide and oligonucleotide prodrugs |
| 09/17/2008 | EP1638992A4 Viral polymerase and modulation thereof |
| 09/17/2008 | CN101268092A Selective O-acylation of nucleosides |
| 09/17/2008 | CN101265284A Method for synthesizing clofarabine |
| 09/16/2008 | US7425547 Nucleoside derivatives for treating hepatitis C virus infection |
| 09/16/2008 | CA2222926C Electrochemiluminescent monitoring of compounds |
| 09/12/2008 | WO2008109675A1 Magnetic bead trap and mass spectrometer interface |
| 09/12/2008 | WO2008109080A2 Nucleoside based proliferation imaging markers |
| 09/12/2008 | WO2008107873A1 Mercaptopurine derivatives as anticancer agents |
| 09/12/2008 | WO2008107771A2 2',3'-di-o-acyl-5-fluoronucleosides |
| 09/12/2008 | WO2008089105A3 Antiviral nucleoside analogs |
| 09/12/2008 | WO2008067002A8 Azole nucleosides and use as inhibitors of rna and dna varial polymerases |
| 09/12/2008 | WO2007150002A3 PRODRUGS OF 5-AMINO-3-(3'-DEOXY-β-D-RIBOFURANOSYL)-THIAZOLO[4,5-d] PYRIMIDIN-2,7-DIONE |
| 09/12/2008 | CA2679700A1 Mercaptopurine derivatives as anticancer agents |
| 09/11/2008 | US20080221060 Therapeutic Compounds |
| 09/10/2008 | EP1967594A2 Detection of nucleic acids by type-specific hybrid capture method |
| 09/10/2008 | EP1753774B1 2"-nitrobenzyl-modified ribonucleotides |
| 09/10/2008 | EP1401851B8 Two-stage protective groups for the synthesis of biopolymers |
| 09/10/2008 | CN101262763A Methods of treating cancer and other conditions or disease states using LFMAU and LDT |
| 09/10/2008 | CN101260135A Method for synthesizing higher fatty acid zidovudine ester |
| 09/09/2008 | US7423144 Purine Derivatives as adenosine A1 receptor agonists and methods of use thereof |
| 09/09/2008 | US7423140 An acceptor fluorophore efficiently absorbs energy emission of a linked donor xanthene fluorophore labelling a oligonucleotide primer, reagent for sequencing nucleic acids, DNA sequencing |
| 09/09/2008 | US7423133 Fluorescent glycosides and methods for their use |
| 09/09/2008 | US7423025 For therapy of cardiovascular disease, ischemia related injuries; and neurodegenerative diseases |
| 09/09/2008 | US7423010 Delivering into phagocytic cells; targeting specific organelles; inhibiting, attenuating, arresting, combating and overcoming microbial infection of phagocytic mammalian cells in vivo and in vitro |
| 09/04/2008 | WO2008028050A3 Reversible natural product glycosyltransferase-catalyzed reactions, compounds and related methods |
| 09/04/2008 | US20080214800 Deacetylase which uses NAD as a cofactor; treating sirtuin related disorders |
| 09/04/2008 | US20080214490 Administering purinergic receptor agonist P1, P4-di(uridine 5'-) tetraphosphate for secretion stimulation; vaginal dryness associated with menopause, chemotherapy, and various disease states as well as the treatment of vulvar pain |
| 09/04/2008 | US20080213809 Coenzyme substrates; kits; nicotinamide adenine dinucleotide; biochemical detection |
| 09/04/2008 | US20080213281 Butyrylcholinesterase Variants that Alter the Activity of Chemotherapeutic Agents |
| 09/04/2008 | CA2679257A1 Compounds for preventing or treating viral infections and methods of use thereof |
| 09/03/2008 | EP1964569A2 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of viral infections |
| 09/03/2008 | EP1962597A2 Purine derivatives and methods of use thereof |
| 09/02/2008 | US7420031 comprises protein transduction domains; nuclear localization sequences; fusion proteins; for reversible immortalization of cells |
| 09/02/2008 | US7419968 Screening for anticancer drugs for treating cells that endogenously overexpress intracellular thymidylate synthase by contacting the cell with the candidate and (E)-5-(2-bromovinyl)-2'-deoxy-5'-uridyl phenyl L-alaninylphosphoramidate and assaying for cell death |
| 09/02/2008 | US7419966 Viricides; human t-cell leukemia, lymphoma virus |
| 09/02/2008 | US7419965 Nucleotide lipid ester derivatives |
| 09/02/2008 | US7419963 Indole antiviral compositions and methods |
| 09/02/2008 | US7419653 Method for preparing radiolabeled thymidine having low chromophoric byproducts |
| 09/02/2008 | CA2440468C Pregabalin lactose conjugates |
| 09/02/2008 | CA2318848C 5'-deoxycytidine derivatives |
| 08/28/2008 | WO2008103618A1 Synthesis of novel xylosides and potential uses thereof |
| 08/28/2008 | US20080207891 Methods For Selective N-9 Glycosylation of Purines |
| 08/28/2008 | US20080207890 provides the combination of the O-2 diphenylcarbamoyl ("DPC") and N-6 dimethy-laminomethylidene ("DMF") protecting groups for isoguanosine nucleosides that can be utilized in oligonucleotide synthesis |
| 08/28/2008 | US20080206764 Flowcell system for single molecule detection |
| 08/27/2008 | EP1960415A2 Phospholipid gel compositions for delivery of aptamers and methods of treating conditions using same |
| 08/27/2008 | EP0649429B1 Heteroatomic oligonucleoside linkages |
| 08/27/2008 | CN101253190A Bate-L-N4-hydroxycytosine deoxynucleosides and their use as pharmaceutical agents in the prophylaxis or therapy of viral diseases |
| 08/27/2008 | CN101250210A Method for synthesizing 5'-chloro-nucleoside |
| 08/27/2008 | CN101250209A Alexan 5'-O-amino acid ester hydrochloride and preparation method thereof |
| 08/27/2008 | CN101250208A L-nucleic acid derivative and processes for the synthesis thereof |
| 08/27/2008 | CN101250194A L-nucleic acid derivative and processes for the synthesis thereof |
| 08/26/2008 | US7417138 applying a reaction sample containing target DNAs to the PNA chip, hybridizing target DNAs with the plurality of probe PNAs, adn target DNAs are labeled with a fluorescent material;washing PNA chip to remove a nonspecific reaction product; detecting a fluorescent signal emitted from PNA/DNA hybrid |
| 08/26/2008 | US7417034 Pharmaceutically active uridine esters |
| 08/26/2008 | US7416858 Forming a convalent conjugate of a peptide, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 08/26/2008 | CA2361614C Compositions for treating inflammatory response |
| 08/26/2008 | CA2304645C Aromatic-substituted xanthene dyes |
| 08/26/2008 | CA2171550C Nucleosides with anti-hepatitis b virus activity |
| 08/21/2008 | WO2008101157A1 5'-substituted-2'-f modified nucleosides and oligomeric compounds prepared therefrom |
| 08/21/2008 | WO2008099492A1 Pyrimidine nucleoside derivative and salt thereof |
| 08/21/2008 | WO2008099203A2 Reactions of isotopically enriched elements of phosphorus, sulfur, selenium and tellurium |
| 08/21/2008 | US20080200423 Novel Tricyclic Nucleosides or Nucleotides as Therapeutic Agents |
| 08/21/2008 | US20080200340 Dispersing the probe beads in a thixotropic agent, scanning for a detectable signal, isolating the target biomolecule; high throughput assays |
| 08/21/2008 | US20080199868 Massive parallel method for decoding DNA and RNA |
| 08/20/2008 | EP1957511A2 Process for the large scale production of stavudine |
| 08/20/2008 | EP1957510A1 Antiviral nucleosides |
| 08/20/2008 | EP1957509A2 Methods and compositions for the treatment of gastrointestinal disorders |
| 08/20/2008 | EP1957086A2 Nicotinoyl riboside compositions and methods of use |
| 08/20/2008 | EP1831237B1 Amide prodrug of gemcitabine, compositions and use thereof |
| 08/20/2008 | EP1451202B1 Aryl fused azapolycyclic compounds |
| 08/20/2008 | EP1198589B1 Tenascin-c nucleic acid ligands |
| 08/19/2008 | US7414118 incorporation of certain modified nucleobases in the 3' terminal region of primers provide reduced formation of primer-dimers during amplification reactions |
| 08/19/2008 | US7414117 Undergoing a change in the fluorescent signal intensity depending on the corresponding base type in the partner strand with which the single-stranded sequence is hybridized |
| 08/19/2008 | US7414116 certain linkers connecting nucleotide bases to detachable labels (fluorophores) are cleaved using water soluble phosphines transition metal catalysts; sequencing; used in nick translation, random primer labeling, end-labeling (terminal deoxynucleotidyltransferase), reverse transcription, amplification |
| 08/19/2008 | US7414115 Annealing primers and complementary Dna forming hybrid; separation; chain extension; immobilization |
| 08/19/2008 | US7414036 Prevent tissue or organ damage; antiischemic agents |